Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

Clinical trial NCT03389256 · UNKNOWN

Trial details

NCT number: NCT03389256
Sponsor: Sichuan Cancer Hospital and Research Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Diseases Neoplasms Respiratory Tract Diseases Thoracic Neoplasms Non-Small-Cell Lung

Start date: 2018-12-30
Primary completion: 2020-12-30
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.